Visualizing Health Policy: US Public’s Perspective on Prescription Drug Costs
US Public’s Opinion of Prescription Drug Costs Download VIEW JAMA INFOGRAPHIC
View the Latest: Prescription Drugs
Filter
-
-
Medicare Part D Beneficiaries Who Reach the Catastrophic Coverage Limit Can Expect to Pay More Out-of-Pocket for Their Prescription Drugs Next Year
News ReleaseMedicare Part D enrollees with relatively high out-of-pocket expenses can expect see their costs rise in 2020, according to a new KFF analysis. This is mainly due to an increase in how much enrollees will pay out of pocket for their prescription drugs in the Part D benefit coverage gap phase before they qualify for catastrophic coverage. The analysis finds that out-of-pocket drug costs will increase by nearly $400 -- from $2,275 in 2019 to…
-
Poll: Democrats Say They Are Hearing Enough From Presidential Candidates About Medicare-for-All and Expanding Coverage, But Want Them to Talk More about Health Costs and Women’s Health Care
News ReleaseHeading into tonight’s Democratic primary debate, most Democrats and Democratic-leaning independents say the candidates are spending the right amount or too much time talking about ways to provide coverage to more Americans and Medicare-for-all, two topics that have dominated health care discussions in the past three rounds of Democratic debates, the latest KFF Health Tracking Poll finds. In contrast, large shares of Democrats and Democratic-leaning independents say that the presidential candidates are spending too little…
-
What Steps Are Washington Policymakers Pursuing to Control Medicare Prescription Drug Spending?
News ReleaseAs policymakers in Washington discuss ways to curb the rising cost of prescription drugs, KFF has released a summary and analysis of proposals and recently finalized initiatives that affect Medicare prescription drug spending. Medicare, the federal health program that covers more than 60 million seniors and younger people with disabilities, accounts for 30 percent of the nation’s retail prescription drug spending. A Look at Recent Proposals to Control Drug Spending by Medicare and its Beneficiaries…
-
Visualizing Health Policy: US Statistics on Surprise Medical Billing
Other PostThis infographic examines public opinion on surprise medical billing in the United States as part of the Visualizing Health Policy infographic series, produced in partnership with the Journal of the American Medical Association (JAMA).
-
Prescription Drug Rebates, Explained
VideoThis animation explains how rebates for prescription drugs work and why they matter in the debate about lowering drug costs. The video breaks down how prescription drug rebates are determined, who benefits from them, how they affect spending by insurers and consumers and the role of pharmacy benefit managers in the process.
-
Explainer Video Breaks Down Prescription Drug Rebates and Why They Matter in the Debate About Prescription Drug Costs
News ReleaseA new KFF animation explains how rebates for prescription drugs work, including how they are determined, who benefits from them, how they affect spending by insurers and consumers and the role of pharmacy benefit managers in the process. The Trump Administration had proposed banning such rebates in Medicare Part D, but dropped the proposal amid concerns that it would lead to higher costs for insurers, consumers and the Medicare program. It is still possible that…
-
Kaiser Health News (KHN) Wins Prestigious Barlett & Steele Investigative Journalism Award
News ReleaseKFF is pleased to announce that Kaiser Health News (KHN), its editorially independent health news service, won a top prize in the 13th annual Barlett & Steele Awards for Investigative Journalism.
-
How Will The Medicare Part D Benefit Change Under Current Law and Leading Proposals?
Issue BriefThis brief describes how the Medicare Part D benefit will change in 2020 under current law and proposed changes that would affect what beneficiaries, plans, manufacturers, and Medicare pay for drug costs under Part D in the future.
-
Where Do the Democratic Candidates Stand on Health Reform and Prescription Drug Prices?
FeatureThis quick primer explains where the 7 Democratic candidates for president participating in the Feb. 25 debate in South Carolina stand on health reform.